company background image
CONTX logo

ContextVision OB:CONTX Stock Report

Last Price

NOK 5.70

Market Cap

NOK 441.0m

7D

7.5%

1Y

-26.0%

Updated

18 Dec, 2024

Data

Company Financials +

ContextVision AB (publ)

OB:CONTX Stock Report

Market Cap: NOK 441.0m

CONTX Stock Overview

A medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. More details

CONTX fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 48.4% below our estimate of its fair value

Revenue is forecast to grow 2.69% per year

Risk Analysis

Earnings are forecast to decline by an average of 4.4% per year for the next 3 years

Does not have a meaningful market cap (NOK441M)

Profit margins (16%) are lower than last year (27.1%)


My Notes

Capture your thoughts, links and company narrative

ContextVision AB (publ) Competitors

CodeLab Capital

OB:CODE

NOK 19.1m

Softmax

TSE:3671

JP¥5.1b

Medistim

OB:MEDI

NOK 2.9b

MeVis Medical Solutions

XTRA:M3V

€44.8m

Price History & Performance

Summary of share price highs, lows and changes for ContextVision
Historical stock prices
Current Share PriceNOK 5.70
52 Week HighNOK 9.20
52 Week LowNOK 4.52
Beta1.08
1 Month Change19.75%
3 Month Change2.15%
1 Year Change-25.97%
3 Year Change-65.24%
5 Year Change-44.66%
Change since IPO54.05%

Recent News & Updates

Recent updates

There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings

Sep 02
There May Be Some Bright Spots In ContextVision's (OB:CONTX) Earnings

ContextVision AB (publ)'s (OB:CONTX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Mar 11
ContextVision AB (publ)'s (OB:CONTX) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

ContextVision's (OB:CONTX) Soft Earnings Are Actually Better Than They Appear

Feb 22
ContextVision's (OB:CONTX) Soft Earnings Are Actually Better Than They Appear

ContextVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18
ContextVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Earnings Not Telling The Story For ContextVision AB (publ) (OB:CONTX)

Jan 26
Earnings Not Telling The Story For ContextVision AB (publ) (OB:CONTX)

When Should You Buy ContextVision AB (publ) (OB:CONTX)?

Jun 22
When Should You Buy ContextVision AB (publ) (OB:CONTX)?

Is There Now An Opportunity In ContextVision AB (publ) (OB:CONTX)?

Jun 16
Is There Now An Opportunity In ContextVision AB (publ) (OB:CONTX)?

Why ContextVision AB (publ) (OB:CONTX) Could Be Worth Watching

Mar 08
Why ContextVision AB (publ) (OB:CONTX) Could Be Worth Watching

Do ContextVision's (OB:CONTX) Earnings Warrant Your Attention?

Apr 19
Do ContextVision's (OB:CONTX) Earnings Warrant Your Attention?

ContextVision AB (publ)'s (OB:CONTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 13
ContextVision AB (publ)'s (OB:CONTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Here's What ContextVision AB (publ)'s (OB:CONTX) Shareholder Ownership Structure Looks Like

Feb 14
Here's What ContextVision AB (publ)'s (OB:CONTX) Shareholder Ownership Structure Looks Like

ContextVision (OB:CONTX) Shareholders Have Enjoyed A Whopping 664% Share Price Gain

Jan 19
ContextVision (OB:CONTX) Shareholders Have Enjoyed A Whopping 664% Share Price Gain

Are ContextVision's (OB:CONTX) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dec 24
Are ContextVision's (OB:CONTX) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Are Robust Financials Driving The Recent Rally In ContextVision AB (publ)'s (OB:COV) Stock?

Nov 28
Are Robust Financials Driving The Recent Rally In ContextVision AB (publ)'s (OB:COV) Stock?

Shareholder Returns

CONTXNO Healthcare ServicesNO Market
7D7.5%-1.1%-2.4%
1Y-26.0%12.5%-0.3%

Return vs Industry: CONTX underperformed the Norwegian Healthcare Services industry which returned 12.7% over the past year.

Return vs Market: CONTX underperformed the Norwegian Market which returned -0.1% over the past year.

Price Volatility

Is CONTX's price volatile compared to industry and market?
CONTX volatility
CONTX Average Weekly Movement5.8%
Healthcare Services Industry Average Movement5.8%
Market Average Movement5.0%
10% most volatile stocks in NO Market11.2%
10% least volatile stocks in NO Market2.7%

Stable Share Price: CONTX has not had significant price volatility in the past 3 months compared to the Norwegian market.

Volatility Over Time: CONTX's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198341Gerald Potzschwww.contextvision.com

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary uses. Its products include Rivent that offers image enhancement and visualization solutions for ultrasound systems for women’s health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, a 2D image enhancement product for handheld units; and Rivent 3D, an image enhancement solution for 3D ultrasound.

ContextVision AB (publ) Fundamentals Summary

How do ContextVision's earnings and revenue compare to its market cap?
CONTX fundamental statistics
Market capNOK 440.99m
Earnings (TTM)NOK 22.28m
Revenue (TTM)NOK 138.83m

19.8x

P/E Ratio

3.2x

P/S Ratio

Is CONTX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CONTX income statement (TTM)
RevenueSEK 135.45m
Cost of RevenueSEK 59.68m
Gross ProfitSEK 75.77m
Other ExpensesSEK 54.03m
EarningsSEK 21.74m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 02, 2025

Earnings per share (EPS)0.28
Gross Margin55.94%
Net Profit Margin16.05%
Debt/Equity Ratio0%

How did CONTX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 13:51
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ContextVision AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tomas SkeivysNorne Securities AS
Juste SubataviciuteNorne Securities AS
Christian LeePareto Securities